
Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? We cover all that and more this week on “The Readout LOUD,” STAT’s …
Read MoreThe latest health news
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? We cover all that and more this week on “The Readout LOUD,” STAT’s …
Read MoreAs inflation-weary shoppers try to make ends meet, many are turning to a modern twist on the layaway plan: buy now, pay later. But while platforms like Afterpay and Affirm …
Read MoreThe World Bank has rolled out a new Financial Intermediary Fund for Pandemic Prevention, Preparedness, and Response (FIF) in an improbable and harmful timetable. Backing of the fund by the …
Read MoreOver the last decade, investors in biotech and pharmaceutical companies have been taking risks that aren’t commensurate with the rewards. That’s what our new analysis of health care investing shows. …
Read MoreYou’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday …
Read MoreThe crisis of opioid overdose deaths that sparked the multitude of lawsuits leading to a historic settlement continues to rage, with overdose deaths at an all-time high despite heightened national …
Read MoreTiffany Yarina didn’t max out her credit card from a home renovation or luxury purchase. It was from cancer. In 2005, Yarina started losing a lot of weight and watched …
Read MoreRetail giant Amazon announced plans Thursday to acquire primary care company One Medical in a cash deal valued at $3.9 billion. The goal of the $18 per share deal is …
Read MoreIt pays to be in the lab. It pays way less to be at the patient’s bedside. People who work at biotechs, life sciences firms, and pharmaceutical companies pull in …
Read More